Medicinal Effects of Bromelain (Ananas comosus) Targeting Oral Environment as an Anti-oxidant and Anti-inflammatory Agent

Jung-Ha Lee¹, Jae-Bong Lee², Jin-Tae Lee², Hae-Ryoun Park¹ and Jin-Bom Kim^1,

¹Pusan National University, South Korea

²Daegu Haany University, South Korea

Cite this paper:
Jung-Ha Lee, Jae-Bong Lee, Jin-Tae Lee, Hae-Ryoun Park and Jin-Bom Kim. Medicinal Effects of Bromelain (Ananas comosus) Targeting Oral Environment as an Anti-oxidant and Anti-inflammatory Agent. Journal of Food and Nutrition Research. 2018; 6(12):773-784. doi: 10.12691/jfnr-6-12-8

Abstract

Bromelain is obtained from Ananas comosus and is of significant clinical interest. Many studies have demonstrated bromelain's ability to treat immune-mediated conditions including reduction of platelet aggregation, angina pectoris and surgical trauma. ROS elimination were evaluated using a variety of anti-oxidation effect tests containing DPPH assay, ABTS+ radical scavenging assay, hydrogen peroxide scavenging assay. Western blotting analysis and RT-PCR were used to investigate an anti-inflammatory agent in LPS-induced RAW cells. Treatment with bromelain exhibited significant scavenging abilities on superoxide radicals compared with control. As results of analyzing iNOS and COX-2 band appearance according to bromelain treatment, it inhibited the band expression dose-dependently. Also bromelain inhibits the phosphorylated-MAP kinases signaling pathways. Furthermore, it reduced c-Fos, phosphorylation of c-Jun and c-Jun. According to the results, it is demonstrated that bromelain of Ananas comosus extract have significant anti-inflammatory ability as well as antioxidant ability.

Keywords:
bromelain anti-oxidant effect anti-inflammatory effect public oral health

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Paroulek AF, Jaffe M, Rathinavelu A. The effects of the herbal enzyme bromelain against breast cancer cell line GI-101A. Doctoral dissertation, Nova Southeastern University (2010).
[2]	Castell JV, Friedrich G, Kuhn CS, Poppe GE. Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol Gastrointest Liver Physiol. 273: G139-G146 (1997).
[3]	Gaciong Z, Paczek L, Bojakowski K, et al. Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model. Nephrol Dial Transplant. 11:987-989 (1996).
[4]	Targoni OS, Tary-Lehmann M, Lehmann PV. Prevention of murine EAE by oral hydrolytic enzyme treatment. J Autoimmun. 12: 191-198 (1999).
[5]	Rovenska E, Svik K, Stancikova M, Rovensky J. Inhibitory effect of enzyme therapy and combination therapy with cyclosporin on collagen-induced arthritis. Clin Exp Rheumatol. 19: 303-309 (2001).
[6]	Majima M, Nishiyama K, Iguchi Y, et al. Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation. Inflamm Res. 45: 416-423 (1996).
[7]	Houck JC, Chang CM, Klein G. Isolation of an effective debriding agent from the stems of pineapple plants. Int J Tissue React. 5:125-134 (1983).
[8]	Abbasi HS, Sabouni F, Moghimi A, Ansari MS, Tafreshi AP. Reduction of NO production in LPS-stimulated primary rat microglial cells by bromelain. J Cell Mol Res. 3:57-65 (2012).
[9]	Hale LP, Greer PK, Trinh CT, Gottfried MR. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol. 116: 135-142 (2005).
[10]	Liu D, Sheng J, Li Z, et al. Antioxidant activity of polysaccharide fractions extracted from Athyrium multidentatum (Doll.) Ching. Int J Biol Macromol. 56: 1-5 (2013).
[11]	Pervin M, Hasnat MA, Lim BO. Antibacterial and antioxidant activities of Vaccinium corymbosum L. leaf extract. Asian Pac J Trop Dis. 3:444-453 (2013).
[12]	Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 48:749-762 (2010).
[13]	Re R, Pellegrini N, Proteggente A, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 26:1231-1237 (1999).
[14]	Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 181:1199-1200 (1958).
[15]	Jayaprakasha GK, Rao LJ, Sakariah KK. Antioxidant activities of flavidin in different in vitro model systems. Bioorganic Med Chem. 12:5141-5146 (2004).
[16]	Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. FEBS J. 47:469-474 (1974).
[17]	Gray JI, Dugan LR. Inhibition of n‐nitrosamine formation in model food systems. J Food Sci. 40:981-984 (1975).
[18]	Silverstein RM, Kezdy FJ. Characterization of the pineapple stem proteases. Arch Biochem Biophys 167:678-686 (1975).
[19]	Rice-evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB: The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22:375-383 (1995).
[20]	Heo JC, Park JY, An SM, et al: Anti-oxidant and anti-tumor activities of crude extracts by Gastrodia elata Blume. Korea J Food Preserv 13:83-87 (2006).
[21]	Singh VK, Mehrotra S, Narayan P, Pandey CM, Agarwal SS: Modulation of autoimmune diseases by nitric oxide. Immunol Res 22:1-19 (2000).
[22]	Kim SO, Kundu JK, Shin YK, et al: [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin. Oncogenes 24: 2558-2567 (2005).
[23]	Kalra N, Bhui K, Roy P, et al: Regulation of p53, nuclear factor κB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol 226:30-37 (2008).
[24]	Aktan F: iNOS-mediated nitric oxide production and its regulation. Life Sci 2004; 75: 639-653.
[25]	Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615 (2001).
[26]	Yang SH, Sharrocks AD, Whitmarsh AJ: Transcriptional regulation by the MAP kinase signaling cascades. Gene 320: 3-21 (2003).
[27]	Dave S, Dkhar HK, Singh MP, et al: Hexafluoroisopropanol-induced helix–sheet transition of stem bromelain: Correlation to function. Int J Biochem Cell Biol 42:938-947 (2010).
[28]	Maurer HR: Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 58:1234-1245 (2001).
[29]	Engwerda CR, Andrew D, Murphy M, Mynott TL: Bromelain activates murine macrophages and natural killer cells in vitro. Cell Immunol 210: 5-10 (2001).
[30]	Engwerda CR, Andrew D, Ladhams A, Mynott TL: Bromelain modulates T cell and B cell immune responses in vitro and in vivo. Cell Immunol 210: 66-75 (2001).
[31]	Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401 (1995).
[32]	Tomimori Y, Tanaka Y, Goto M, Fukuda Y: Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition. J Invest Dermatol 124: 119-124 (2005).
[33]	Misra HP, Fridovich I: The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170-3175 (1972).
[34]	Awika JM, Rooney LW, Wu X, Prior RL, Cisneros-Zevallos L: Screening methods to measure antioxidant activity of sorghum (Sorghum bicolor) and sorghum products. J Agric Food Chem 51: 6657-6662 (2003).
[35]	Hoffmann MR, Martin ST, Choi W, Bahnemann DW: Environmental applications of semiconductor photocatalysis. Chem Rev 95: 69-96 (1995).
[36]	Kim BH, Lee YT, Kang KH: Codonopsis lanceolata inhibits inflammation through regulation of MAPK in LPS-stimulated RAW264. 7 cells. J Physiol & Pathol Korean Med 24 (2010).
[37]	Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593 (2001).
[38]	Huang JR, Wu CC, Hou RCW, Jeng KC: Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. Immunol Invest 37: 263-277 (2008).
[39]	Liu T, Clark RK, McDonnell PC, et al: Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25: 1481-1488 (1994).
[40]	Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912 (2002).